Home » Topics » Regulatory

Regulatory
RSS

FDA approves Organon's short-acting neuromuscular blocker Raplon

Aug. 19, 1999

FDA approves Cleocin vaginal ovules for treatment of bacterial vaginosis

Aug. 19, 1999

Etanercept trial results in psoriatic arthritis announced

Aug. 18, 1999

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Aug. 16, 1999

Bayer will launch new quinolone on September 1

Aug. 13, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

CPMP adopts positive opinion concerning reformulated Norvir capsules

Aug. 13, 1999

FDA further expands approved indications for Zocor

Aug. 11, 1999

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

U.K.'s MCA is first to approve Synercid for marketing

Aug. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...